Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).

Shimoda M, Katakura Y, Mashiko A, Iwamoto M, Nakanishi S, Anno T, Kawasaki F, Obata A, Fushimi Y, Sanada J, Kohara K, Isobe H, Iwamoto Y, Hirukawa H, Tatsumi F, Kimura Y, Kimura T, Mune T, Kaku K, Kaneto H

Open source

DOI: 10.3389/fendo.2024.1412553
Published: 2024
Container: Frontiers in endocrinology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2024.1412553,
  title = {Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).},
  author = {Shimoda M and Katakura Y and Mashiko A and Iwamoto M and Nakanishi S and Anno T and Kawasaki F and Obata A and Fushimi Y and Sanada J and Kohara K and Isobe H and Iwamoto Y and Hirukawa H and Tatsumi F and Kimura Y and Kimura T and Mune T and Kaku K and Kaneto H},
  year = {2024},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2024.1412553},
  url = {https://doi.org/10.3389/fendo.2024.1412553}
}

RIS

TY  - JOUR
TI  - Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).
AU  - Shimoda M
AU  - Katakura Y
AU  - Mashiko A
AU  - Iwamoto M
AU  - Nakanishi S
AU  - Anno T
AU  - Kawasaki F
AU  - Obata A
AU  - Fushimi Y
AU  - Sanada J
AU  - Kohara K
AU  - Isobe H
AU  - Iwamoto Y
AU  - Hirukawa H
AU  - Tatsumi F
AU  - Kimura Y
AU  - Kimura T
AU  - Mune T
AU  - Kaku K
AU  - Kaneto H
PY  - 2024
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2024.1412553
UR  - https://doi.org/10.3389/fendo.2024.1412553
ER  -

APA

M, S., Y, K., A, M., M, I., S, N., T, A., F, K., A, O., Y, F., J, S., K, K., H, I., Y, I., H, H., F, T., Y, K., T, K., T, M., K, K., & H, K. (2024). Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2024.1412553

Source records

pubmed · retrieved 2026-09-27T10:16:10.607Z
europe-pmc · retrieved 2026-09-27T10:16:10.607Z
doaj · retrieved 2026-09-27T10:16:10.623Z